Investors may believe Kaisa Health Group Holdings will underperform the broader industry, given its low P/S ratio, declining revenue, and the industry's projected 67% growth. The P/S ratio could fall even lower without top-line growth improvement.
Kaisa Health Group's low P/S ratio may indicate expected poor revenue performance. The company's declining revenue trend compared to industry growth is worrying, suggesting share price may remain stagnant if trends continue.
佳兆業健康股票討論區
凱薩表示已經遇到前所未有的流動性壓力,而財富管理產品保證因其錯過付款。.
$佳兆業集團(01638.HK)$
$佳兆業美好(02168.HK)$
$佳兆業資本(00936.HK)$
$佳兆業健康(00876.HK)$
暫無評論